Implications of new obesity definitions in the classification and outcomes of patients with MASLD [0.03%]
新型肥胖定义对MASLD患者分类和预后的影响
Jie Cai,Terry Cheuk-Fung Yip,Huapeng Lin et al.
Jie Cai et al.
Background aims: New obesity definitions beyond body mass index (BMI) have recently been proposed. This study aimed to assess the proportion of obesity under these frameworks and their associations with liver-related even...
Erratum: RNF128 aggravates metabolic dysfunction-associated steatotic liver disease progression via stabilization of SCD1 [0.03%]
Correction: RNF128通过稳定SCD1促进与代谢紊乱相关的脂肪性肝病进展
Lei Cao,Wei Yang,Chaofan Wang et al.
Lei Cao et al.
Recompensation of decompensated cirrhosis in a spectrum of metabolic-dysfunction-related steatotic liver disease, with PEth-corroborated alcohol abstinence and modification of cardiometabolic risk factors [0.03%]
在代谢紊乱相关肝脂肪变性疾病的谱系中，经PEth证实已戒酒并修改了心脏代谢危险因素的失代偿期肝硬化患者的代偿转换疗法
Madhumita Premkumar,Anchal Sandhu,Prerna Sharma et al.
Madhumita Premkumar et al.
Background aims: Recompensation of decompensated metabolic-dysfunction-associated steatotic liver disease (MASLD) and Metabolic Dysfunction-Associated Steatotic Liver Disease with Alcohol Consumption (MetALD) cirrhosis re...
Retraction: HSP72 interacts with PRDX6 to deubiquitinate mitochondrial PINK1, activating mitophagy to treat MASLD [0.03%]
撤稿：HSP72通过与PRDX6相互作用对线粒体PINK1去泛素化，以激活自噬作用来治疗MASLD
Yong Rao,Rui Su,Wen-Jie Cao et al.
Yong Rao et al.
Erratum: Noninvasive assessment of liver disease severity in NAFLD and T2D [0.03%]
NAFLD和2型糖尿病患者肝病严重程度的非侵入性评估的勘误说明
Grazia Pennisi,Marco Enea,Vincenzo Falco et al.
Grazia Pennisi et al.
Erratum: AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis [0.03%]
关于急性-on慢性肝功能衰竭以及管理严重肝硬化患者的AASLD实践指南的勘误表
Constantine J Karvellas,Jasmohan S Bajaj,Patrick S Kamath et al.
Constantine J Karvellas et al.
Erratum: AlphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma [0.03%]
肝癌中αB晶体蛋白与14-3-3ζ的复合物通过上皮间质转化诱导索拉非尼耐药的校正原文作者: Chen Jie, Yang Yu-Lin, Xiong Lian-Qiu, Li Jian-Bing, Liu Jin-Tao, Luo Qing-Yi, Lin Hong-Wu, Zhang Bin, Guo Ru-Hong, Cai Shi-Wu, Shen Qiang, Tang Ran, Zhao Yan-Yan, Zhou Xiao-Mei, Zhang Yu-Xin, Wang Jia-Rui, Huang Zhi-Qiang, Yang Xue-Feng, Chen Ming-Jie,
Huang Xiao-Yong,Ke Ai-Wu,Shi Guo-Ming et al.
Huang Xiao-Yong et al.
Pizza versus Pi*ZZ: The metabolic amplifiers in alpha-1 antitrypsin deficiency [0.03%]
披萨与Pi*ZZ：α1抗胰蛋白酶缺乏症中的代谢放大器
John Grady,Juan Pablo Arab
John Grady
The liver joins the CKM conversation: Fibrosis risk across the cardiometabolic spectrum [0.03%]
肝病加入CKD对话：代谢心血管疾病谱上的肝纤维化风险评估
Omar Albhaisi,Juan Pablo Arab
Omar Albhaisi